Singaporean AI overall health tech startup Bot MD has entered into partnerships with key Indonesian organisations to utilise AI assistant technologies in driving patient and clinician expertise.
WHAT It is ABOUT
The startup signed a memorandum of understanding with Siloam Hospitals Group to automate and scale patient-reported outcome measures (PROM) across its hospital chain by powering Siloam’s WhatsApp with the Bot MD Care AI chatbot.
Through visits, the chatbot automatically notifies individuals by means of WhatsApp to gather their baseline health-related situation. It automatically reminds them and collects their PROMs pre- and post-surgery and then scores their outcomes. The AI platform can also provide automatic reminders and education facts to individuals.
Bot MD Care is now accessible to individuals getting remedies for heart failure or ischemic heart illness at Siloam Hospitals Lippo Village in Tangerang. There are also plans to progressively roll out the AI service across other hospitals later. Siloam Hospitals will also expand the service to cover other clinical places and integrate it into its EMR program to make it less complicated for clinicians to critique patient progress.
Meanwhile, Bot MD also partnered with the Indonesian Health-related Association (IDI) to embed its AI assistant on the latter’s web page. This integration enables extra than 200,000 medical professional members of the organisation to immediately search for association facts, IDI solutions and national suggestions.
Via the IDI Bot, medical doctors can conveniently seek facts on new memberships, apply for an electronic membership card, report troubles with membership activation, renew their competency certificate, and submit feedback to IDI. Obtainable in each Bahasa Indonesia and English, the IDI Bot has been educated on often asked queries from IDI members.
WHY IT MATTERS
As a single of Indonesia’s biggest private hospital groups with 41 hospitals and 66 clinics, Siloam treats and offers care for extra than 5 million one of a kind individuals every year. Adopting an AI chatbot will assist scale its information collection across a variety of clinical circumstances, as properly as benchmark and measure patient outcomes across its hospitals, which in the end informs clinicians in improving their quality of care.
Meanwhile, Bot MD is supporting IDI’s digital transformation journey to strengthen the high quality and availability of its solutions. The association is keen to expand its partnership with the startup in the future by powering WhatsApp and its other chat platforms with AI to strengthen access to solutions for its members.
Following optimistic outcomes from this partnership, Bot MD now plans to introduce the service to other health-related associations across Southeast Asia.
THE Bigger TREND
Two years ago, Bot MD raised $five million in a funding round which went to its regional expansion efforts. The business had locked its sights on Indonesia, the Philippines, Malaysia and India.
Through the pandemic, its AI assistant has been deployed across public hospitals in Singapore to aid with remote very important indicators monitoring and collection.
